Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunotherapy in leukaemia. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37272727 | PubTator, text mining | PubMed |
| Haploinsufficiency of the essential gene Rps12 causes defects in erythropoiesis and hematopoietic stem cell maintenance. | Elife | 2023 | 37272618 | PubTator, text mining | PubMed |
| Polycomb repressive complex 1.1 coordinates homeostatic and emergency myelopoiesis. | Elife | 2023 | 37266576 | PubTator, text mining | PubMed |
| Obesity contributes to hepatocellular carcinoma development via immunosuppressive microenvironment remodeling. | Front Immunol | 2023 | 37266440 | PubTator, text mining | PubMed |
| Both maternal IFNγ exposure and acute prenatal infection with Toxoplasma gondii activate fetal hematopoietic stem cells. | EMBO J | 2023 | 37259639 | PubTator, text mining | PubMed |
| Risk prediction for dermatomyositis-associated hepatocellular carcinoma. | BMC Bioinformatics | 2023 | 37259059 | PubTator, text mining | PubMed |
| Impact of redox-related genes on tumor microenvironment immune characteristics and prognosis of high-grade gliomas. | Front Cell Neurosci | 2023 | 37252189 | PubTator, text mining | PubMed |
| SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy. | Front Immunol | 2023 | 37251372 | PubTator, text mining | PubMed |
| Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma. | Cancer Res | 2023 | 37249584 | PubTator, text mining | PubMed |
| Identification of ferroptosis and drug resistance related hub genes to predict the prognosis in Hepatocellular Carcinoma. | Sci Rep | 2023 | 37248280 | PubTator, text mining | PubMed |
| Systemic alterations in neutrophils and their precursors in early-stage chronic obstructive pulmonary disease. | Cell Rep | 2023 | 37243592 | PubTator, text mining | PubMed |
| An unusual association between Burkitt's lymphoma and a Carcinoid tumor in a Syrian boy: a rare case report. | Ann Med Surg (Lond) | 2023 | 37228974 | PubTator, text mining | PubMed |
| Maternal dendritic cells influence fetal allograft response following murine in-utero hematopoietic stem cell transplantation. | Stem Cell Res Ther | 2023 | 37226255 | PubTator, text mining | PubMed |
| GDF15 Mediates the Effect of Skeletal Muscle Contraction on Glucose-Stimulated Insulin Secretion. | Diabetes | 2023 | 37224335 | PubTator, text mining | PubMed |
| Function and prognostic value of basement membrane -related genes in lung adenocarcinoma. | Front Pharmacol | 2023 | 37214471 | PubTator, text mining | PubMed |
| A novel score system based on arginine metabolism-related genes to predict prognosis, characterize immune microenvironment, and forecast response to immunotherapy in IDH-wildtype glioblastoma. | Front Pharmacol | 2023 | 37214463 | PubTator, text mining | PubMed |
| Cytokines induced memory-like NK cells engineered to express CD19 CAR exhibit enhanced responses against B cell malignancies. | Front Immunol | 2023 | 37207215 | PubTator, text mining | PubMed |
| TYROBP-positive endothelial cell-derived TWEAK as a promoter of osteosarcoma progression: insights from single-cell omics. | Front Oncol | 2023 | 37207157 | PubTator, text mining | PubMed |
| Probing the Potential of Defense Response-Associated Genes for Predicting the Progression, Prognosis, and Immune Microenvironment of Osteosarcoma. | Cancers (Basel) | 2023 | 37190333 | PubTator, text mining | PubMed |
| Non-Inflamed Tumor Microenvironment and Methylation/Downregulation of Antigen-Presenting Machineries in Cholangiocarcinoma. | Cancers (Basel) | 2023 | 37190307 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=21